Filter
440
Text search:
booster
Featured
Recommendations
37
New Publications
91
Language
Document type
No document type
194
Guidelines
104
Studies & Reports
55
Fact sheets
26
Manuals
18
Strategic & Response Plan
18
Situation Updates
8
Training Material
7
Brochures
4
Resource Platforms
2
Infographics
2
Videos
2
Countries / Regions
India
27
Global
23
Congo, Democratic Republic of
11
South Africa
11
Brazil
8
Western and Central Europe
8
Africa
8
Philippines
7
Mozambique
7
Ukraine
7
Senegal
6
Germany
6
Tanzania
6
Argentina
6
Namibia
6
Zambia
5
Latin America and the Carribbean
5
Nigeria
4
Colombia
4
Lesotho
4
East and Southern Africa
4
Ghana
3
Uganda
3
Kenya
3
Rwanda
3
Myanmar / Burma
3
Liberia
2
Zimbabwe
2
Nepal
2
Indonesia
2
Benin
2
West and Central Africa
2
South–East Asia Region
2
Western Pacific Region
2
Venezuela
2
Eastern Europe
2
Burkina Faso
1
Sierra Leone
1
Ethiopia
1
Niger
1
Haiti
1
Bangladesh
1
Switzerland
1
Burundi
1
Ecuador
1
Botswana
1
Madagascar
1
Chile
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Fiji
1
Russia
1
Moldova
1
France
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
156
Clinical Guidelines
71
Women & Child Health
23
Public Health
19
Key Resources
11
Capacity Building
4
Pharmacy & Technologies
2
Toolboxes
COVID-19
88
HIV
27
TB
24
Mental Health
18
NTDs
17
Polio
13
Refugee
13
Malaria
13
Pharmacy
10
Conflict
9
Rapid Response
8
Caregiver
8
Ebola & Marburg
5
Natural Hazards
5
Planetary Health
5
AMR
4
NCDs
4
Global Health Education
3
Disability
2
Cholera
2
Health Financing Toolbox
2
Specific Hazards
1
September 2021
Guidelines for the Vaccination Scheme against
COVID 19: Booster Dose Health Personnel
Memorandum: Recommendation of interval for the application of the booster dose of COVID-19 vaccines
How much protection does the current batch of COVID-19 vaccines provide us? Would you need a booster shot for new variants? What does science and evidence tell us about mass gatherings and the spread of COVID-19?
WHO’s Chief Scientist Dr Soumya
...
Neonatal tetanus (NT), a severe newborn illness from the toxigenic strains of Clostridium tetani, persists in middle- and low-income countries due to non-sterile childbirth practices. Unlike smallpox and polio, tetanus cannot be eradicated: Clostridium tetani spores exist in the environment, and ani
...
17 Febr. 2022. As part of the “Strategy to Achieve Global COVID-19 Vaccination by mid-2022”, global targets of 40% population coverage by end of 2021 and 70% coverage by June 2022 have been set by the World Health Organization (WHO), to successfully prevent severe illness and deaths, minimize so
...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition
...
Additional dose of the primary vaccination against COVID-19: Technical Guidelines
Ethnic disparities in COVID-19 persist, with increased rates of infection, severe disease, and death among people from minority ethnic groups. COVID-19 vaccination rates also remain lowest in these communities compared with white people in the UK. Among people older than 18 years, the proportion who
...
Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfemp
...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc
...
